Paper
13 March 2024 Noninvasive nanoimaging-nanomanipulation of CRISPR-Cas in cells
Di Zu, Borui Li, Somin Eunice Lee
Author Affiliations +
Proceedings Volume 12860, Plasmonics in Biology and Medicine XXI; 1286006 (2024) https://doi.org/10.1117/12.3005864
Event: SPIE BiOS, 2024, San Francisco, California, United States
Abstract
CRISPR-Cas9 is significantly potential and versatile gene-editing treatment for neurodegenerative disorders. The CRISPR-Cas9 system incorporates a single guide RNA (sgRNA) and Cas9 nuclease, which helps system to bind to the target sequence, and makes a double-strand break respectively. Viral vectors, as traditional delivery system of CRISPRCas9, cause safety issue regrading immunogenic complications. In this work we present alternative non-viral vectors with plasmonic properties as a delivery system. Our work provides a new perspective of nanoparticles for delivery and visualization applications of the CRISPR-Cas9 system.
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Di Zu, Borui Li, and Somin Eunice Lee "Noninvasive nanoimaging-nanomanipulation of CRISPR-Cas in cells", Proc. SPIE 12860, Plasmonics in Biology and Medicine XXI, 1286006 (13 March 2024); https://doi.org/10.1117/12.3005864
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Optical tweezers

Alzheimer disease

Integrated optics

Nanoimaging

Proteins

Visualization

Back to Top